Nearly 4 in 10 clinical trials based on false information; FDA routinely ignores blatant science fraud
Natural News | 8 March 2015 One of the most important responsibilities of the Food and Drug Administration (FDA) in protecting public health is to conduct regular inspections of clinical trial sites to ensure that good clinical practices are being followed. But a new study published in the peer-reviewed journal JAMA Internal Medicine has found…